ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Researchers Identify Subtype Demonstrating Angiogenesis

February 24, 2012

CCI Will Tackle Reimbursement Issue

May 16, 1980

NCI Announces Designation Of Comprehensive Center

July 20, 1990

In Brief: Move To NCI director’s Office gives Greater Visibility To NCI Liaison Office

September 13, 1996

Still Misperceptions On Hill About CRADA Between NCI, BMS

March 13, 1992

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

June 9, 2006